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hypothesized that increasing and stabilizing the ECM
secreted from cells may enhance cell adhesion and there-
fore improve cell retention on the prosthetic graft.
Because smooth muscle cells (SMC) secrete a significantly
larger amount of ECM than do EC, SMC could be used
to improve cellular adhesion onto prosthetic materials.
The seeding of SMC on grafts has been studied by other
investigators,7,8 but not in the context of enhancing EC
seeding and retention. Another advantage of SMC is that
the multilayer configuration of SMC provides more
“exogenous gene product forming” units per unit volume
than a monolayer of EC.
Tissue plasminogen activator (tPA), a thrombolytic
protease, can be overexpressed in EC and SMC after gene
transfer.9,10 This enzyme converts inactive plasminogen
into active plasmin, which then degrades fibrin complexes,
a major component of a thrombus. The wild-type tPA has
high protease activity when it is secreted from cells as a sin-
gle chain.11 A problem encountered with the seeding of
wild-type tPA excreting cells is that overexpression of tPA
will induce nonspecific proteolysis of the supporting extra-
cellular matrix, thus decreasing the retention of seeded EC
on prosthetic grafts.12,13
A zymogen tPA mutant (R275E, A292S, F305H),14
which is secreted as an inactive precursor in single-chain
form, with a 200-fold reduction in catalytic efficiency as
compared with the wild-type tPA, retains full activity when
cleaved into two-chain form after binding to fibrin. Its low
Seeding the prosthetic grafts with endothelial cells
(EC) was proposed to reduce surface thrombogenicity of
vascular grafts.1,2 In the study by Deutsch et al,3 a 9-year
patency rate of EC-seeded polytetrafluoroethylene
(PTFE) grafts was 65%, versus 16% for the unseeded con-
trol group, whereas Jensen et al4 showed that the long-
term outcome was not obviously influenced by EC
seeding. The failure of cell seeding has been blamed for
the poorly adherent EC that were stripped off the pros-
thetic surface when exposed to blood flow.
Extra cellular matrix (ECM) (collagens, proteogly-
cans, elastin, etc) secreted from cells contributes signifi-
cantly to the adherence of cells to the prosthetic grafts.
The precoating ECM on the surface of PTFE grafts has
been shown to benefit cell seeding and adhesion.5,6 We
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Objective: The purpose of this study was to enhance the retention of seeded endothelial cells (EC) on prosthetic vascu-
lar grafts. Dual-layer EC and smooth muscle cell (SMC) seeding and gene transfer of a zymogen tissue plasminogen
activator gene (tPA) into seeded EC were studied.
Methods: Polytetrafluoroethylene (PTFE) grafts were precoated with fibronectin, seeded with SMC followed by EC a
day later, and then, 24 hours later, exposed to an in vitro flow system for 1 hour. Cell retention rates were determined
for grafts seeded with EC only, a dual layer of EC on top of SMC, EC transduced with wild-type tPA, and EC trans-
duced with zymogen tPA.
Results: Seeding efficiency of PTFE pretreated with fibronectin was 260 ± 8 cell/mm2. After exposure to flow, only 39%
± 14% of the EC were retained when EC were seeded alone, whereas 73% ± 22% of EC remained on grafts when EC were
seeded on top of SMC (P < .001, n = 10). The enzyme activity of a mutant zymogen tPA in absence of fibrin was 14 ±
1 IU/mL, which is 3.6-fold lower than that in the presence of fibrin (50 ± 19 IU/mL), whereas fibrin has no effect on
the wild-type tPA activity. EC expressing a high level of wild-type tPA had a lower retention rate (37%) when compared
with normal EC (45%). EC expressing the mutant zymogen tPA had an improved retention rate (54%, P = .001, n = 10)
in absence of fibrin, whereas its retention rate was reduced to 43% when the cells were exposed to fibrin.
Conclusion: SMC seeded between EC and PTFE improves EC retention in vitro. Transduction of zymogen tPA increases
thrombolytic ability of seeded cells with less adverse impact on cell retention than wild-type tPA. (J Vasc Surg
2001;34:337-43.)
protease activity, once secreted from the cell, should
exhibit limited digestion of the ECM. The increased tPA
expression should therefore have little adverse effect on
cellular adhesion while maintaining its thrombolysis ability
when it is bound to fibrin within the thrombus.
In this study, an SMC cellular layer between seeded
EC and the graft surface was used to enhance EC reten-
tion on prosthetic grafts. The gene encoding the zymogen
tPA mutant was transduced into seeded EC to avoid the
adverse effects of wild-type tPA on cell adhesion while
being able to enhance the antithrombotic activity of
seeded cells.
MATERIAL AND METHODS
Cell culture. The 293T/17 cells (CRL11268)15
were obtained from American Type Culture Collection
and maintained in Dulbecco modified Eagle medium
(DMEM) (Gibco BRL, Gaithersburg, Md) supplemented
with 10% fetal bovine serum (HyClone, Logan, Utah) and
glutamine 2 mmol/L (Gibco BRL). The 293/GPG cell
line, a vesicular stomatitis virus G glycoprotein (VSV-G)
pseudotyped murine leukemia viral vector (MuLV) pack-
aging cell line, was provided by Ory et al16 and maintained
in DMEM described above with additional tetracycline 1
µg/mL (Sigma Chemical Co, St Louis, Mo), puromycin 2
µg/mL (Sigma Chemical Co), G418 0.3 mg/mL (Gibco
BRL), and 1 mmol/L MEM sodium pyruvate (Gibco
BRL) and has constantly expressed gag-pol genes and tet
promotor-controlled VSV-G genes. All cells were main-
tained in a humidified incubator at 37°C with 5% CO2.
Isolation of EC and SMC. Human saphenous vein
EC and SMC were isolated as described previously17 from
human saphenous veins, which was approved by the
Institutional Review Board (IRB 969-042). EC were cul-
tured in MCDB 131 medium as described.18 SMC were
cultured in Williams’ medium (Gibco BRL) supplemented
with glutamine 2 mmol/L and 20% fetal bovine serum.
Plasmids. Plasmids containing the cDNA encoding for
wild-type and zymogen tPA (tPA/R275E,F305H,A292S)14
were provided by Dr Edwin Madison (Corvas International
Inc, San Diego, Calif). The retroviral vector plasmids
pG1wTSvNa and pG1zTSvNa carrying wild-type tPA 
and mutant zymogen tPA, respectively, were generated by
inserting the Xba I fragments of ptPA and ptPA/
R275E,F305H,A292S into G1X SvNa (obtained from Genetic
Therapy, Inc/Novartis, Gaithersburg, Md). Retroviral vec-
tor, pLGFPSN,19 was used for green fluorescence protein
(GFP) expression.
Retroviral production and cell transduction. The
replication-incompetent VSV-G pseudotyped MuLV vec-
tors were first generated from a transient three-plasmid
transfection system as described previously.20 The viral
supernatants from the transient transfection were used to
transduce packaging cell line 293/GPG. The pools of the
transduced 293/GPG were named as 293/GPG/X, where
X represents different vectors: G1nBgSvNa, G1wTSvNa,
G1zTSvNa, and LGFPSN. The cell lines 293/GPG/X,
without selection, were used as stable-vector producer
cells because the transduction efficiency of VSV-G
pseudotyped MLV vector is higher than 90%.20 After 
the 293/GPG/X cells were cultured in DMEM with
tetracycline to 90% confluence, the cells were washed with
phosphate-buffered saline solution (PBS) and then further
cultured in the fresh aforementioned DMEM but without
tetracycline. At every 24 hours, retroviral supernatants
were collected and replaced with fresh culture medium.
The collected culture medium (up to 72 hours) was fil-
tered through a 0.45-µm pore-size filter (Pall Gelman,
Ann Arbor, Mich) and stored at –80°C for further use.
The viral titers were between 106 to 107 colony formation
units per milliliter as analyzed by neomycin resistance
assay. All gene transfers were mediated with the VSV-G
pseudotyped MuLV (VSV-G/MuLV) vectors generated
from the producer cell lines 293/GPG/X. Transduction
of EC and SMC with viral vectors was as described21 by
mixing the cells with viral supernatants and with 8 µg
polybrene for 2 hours, followed by G418 (Gibco BRL)
selection.
Determination of tPA concentration. EC, regard-
less of whether they were tPA gene transduced, were cul-
tured in a 24-well plate to 90% confluence and then
washed once with PBS. The culture medium was replaced
with 1-mL serum-free EC medium and collected after 24-
hour culture with the cells. The tPA fibrinolytic enzyme
activity of the cell culture supernatant was determined by a
chromogenic assay with the Chromolize tPA assay kit from
Biopool (Ventura, Calif). The concentration of tPA in the
supernatant was determined by measuring the tPA antigen
concentration with an enzyme-linked immunosorbent
assay kit (TintElize tPA) from Biopool. The enzyme-linked
immunosorbent assay kits recognize both wild-type and
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Fig 1. Cell seeding on PTFE grafts coated with different matrix.
PTFE grafts (5-mm internal diameter) were either rinsed (open
bar) or squeezed (filled bar) with matrix materials indicated. EC
were grown on luminal surface of graft. Cell number was counted
1 day after cell seeding. Cell density on PTFE grafts was pre-
sented as mean ± SE from eight experiments with 10 to 36 seeded
grafts.
zymogen tPA. In the experiments of fibrin effect on tPA
activity and cell retention, the fibrin (America Diagonostic,
25 µg/mL) was added to the reaction mixture or the
medium in circuit system for in vitro flow study.
Cell seeding. Expanded PTFE grafts (regular wall
thickness, internal diameter 5 mm) were provided by
IMPRA, Inc (Tempe, Ariz). The grafts were coated with
either fibronectin (0.1 mg/mL in PBS, Gibco BRL),
Matrigel matrix (1:3 dilution, Becton Dickinson, Franklin
Lake, NJ), gelatin (1%, Sigma Chemical Co), or PBS (con-
trol) for the seeding condition experiment. The coating
treatment was either the grafts were rinsed with the solu-
tions and air-dried, or the solution was squeezed through
the graft wall by holding both ends of solution-filled graft
and pressuring the agent into the graft wall.6 Beyond the
seeding condition experiment, the fibronectin-squeezed
grafts were used for all further cell seeding experiments.
After the coating, the grafts were filled with cells (3 × 105
cells/mL) dissociated from 100-mm plates, heat-crimped
at both ends, and rotated at 1 rpm for 2 hours at 37°C.
Then the ends of the graft were opened, and cell suspen-
sion was removed. The grafts were cultured in a 100-mm
culture dish with EC medium for 1 day before being
tested in flow circuit.
For single-cell seeding, both EC and SMC were trans-
duced with retroviral vectors carrying the lacZ gene. The
grafts were stained with either X-gal20 or hematoxylin and
eosin to visualize the seeded cells, and the cell numbers
were counted under a microscope. For dual-layer seeding,
EC and SMC were transduced with the lacZ gene and
gene coding for GFP, respectively. EC and SMC were
readily distinguishable by X-gal staining and fluorescent
microscopy. SMC were seeded on PTFE grafts squeezed
with fibronectin as described above. The grafts were cul-
tured for 1 day before EC were seeded over the SMC. In
the experiments of tPA effect on cell retention, only EC-
seeded grafts were used.
In vitro flow studies. A pulsatile in vitro flow circuit
housed in a tissue culture incubator was constructed to
evaluate retention of seeded cells. A pulsatile blood pump
(model 1421, Harvard Apparatus, South Natick, Mass)
pumped MCDB 131 medium at 500 mL/min at 70
strokes/min with 100 mm Hg systolic pressure through a
pair of PTFE grafts (5-mm internal diameter) in parallel,
generating a shear stress of 6.1 dyne/cm2 by use of the
formula 4ηQ/πr3 with η as the viscosity of the medium
(0.009 g/cm × sec), Q as the flow rate in mL/sec, and r
as the graft radius.22
Before connecting to the flow circuit, one fourth of
the graft (1 cm) was cut as a preflow control. The cell-
seeded grafts were placed in the flow circuit for 60 min-
utes. After this flow exposure, the graft segments were
removed from the pump and rinsed with PBS. Both pre-
flow and postflow grafts were fixed with 10% formalde-
hyde. The grafts were stained with X-gal to visualize the
seeded cells. The number of residual cells were counted by
use of a microscope and expressed as cell density in cells
per millimeters squared. For dual-layer–seeded grafts, EC
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were quantitatively examined under bright-field micro-
scopy, and the SMC were quantitatively examined under
fluorescent microscopy.
Statistical analyses. All values are expressed as mean
± SEM. Mean values for continuous variables were com-
pared with analysis of variance and paired 2-tailed
Student t tests. Significance was attributed to a P value of
less than .05.
RESULTS
Seeding cells on grafts. Squeezing the matrix
through the PTFE wall significantly increases the cell
seeding efficiency for every matrix tested (P < .05, Fig 1).
The best seeding efficiency resulted from PTFE coated
with fibronectin by the squeeze-through technique and
was about fivefold higher than that of nonsqueezed PTFE
coated with fibronectin (55 ± 6 cells/mm2, n = 25). The
cell density on the surface of PTFE reached 260 ± 8
cell/mm2 (n = 36) after 1 day of culture, which was
twofold higher than that of the squeeze through with
Matrigel (118 ± 3 cell/mm2, n = 26). Only a few cells (1
cell/mm2) were successfully seeded on PBS-rinsed PTFE
grafts.
Dual-layer cell seeding. EC and SMC, before being
seeded, were transduced with the marker genes lacZ and
GFP, respectively, to distinguish SMC from EC on the
double-seeded graft. The two cell types were readily dis-
tinguishable by X-gal staining (for detection of EC, Fig 2,
A) and fluorescent microscopy (for detection of SMC, Fig
2, B). The densities of EC seeded on PTFE, either single-
cell EC seeding or dual-layer seeding, are similar, inde-
pendent of prior SMC seeding (358 cells/mm2 for
single-cell seeding vs 330 cells/mm2 for dual-layer seed-
ing, Table I). SMC growing on a culture dish have a flat-
tened stellate appearance (Fig 2, C), whereas the structure
of SMC is elongated and spindle shaped while growing on
PTFE (Fig 2, D).
Cell retention after in vitro flow. After the PTFE
grafts were exposed to in vitro flow for 60 minutes,
approximately 60% of EC were lost when the cells had
been seeded on a graft alone (retention rate 39%, Table I,
Fig 3, A and D). SMC seeded alone had a better retention
(64%, Fig 3, B and E) than EC seeded alone (39%, P <
.001, n = 10). The retention rate of EC seeded on top of
SMC (73%) was significantly higher than that of EC
seeded alone (P < .001, n = 10, Fig 3, C and F).
Effect of tPA on cell retention. After EC were trans-
duced with retroviral vectors carrying genes encoding
either the wild-type tPA or mutant zymogen tPA, the con-
centration and activity of tPA in the supernatants of the
cell cultures were assayed in the presence and the absence
of fibrin. The tPA production increased to 133 ± 38
ng/mL and 230 ± 64 ng/mL of EC transduced with
wild-type tPA and zymogen tPA, respectively, from 10 ± 3
ng/mL of the nontransduced EC. Fibrin did not have a
significant effect on the activity of wild-type tPA (Table
II). However, the zymogen mutant tPA had lower enzyme
activity without fibrin (14 ± 1 IU/mL) than with fibrin
(50 ± 19 IU/mL) because of its secretion in the inactive
precursor form. The enzyme activity of zymogen was less
than half the activity of wild-type tPA in the absence of fi-
brin, whereas it was higher than that of wild-type tPA in
the presence of fibrin (Table II).
We then accessed the effect of tPA expressions on cell
retention. PTFE grafts were seeded with EC or tPA-
transduced EC and then exposed to flow in vitro for 60
minutes in the presence or absence of fibrin as described
above. The retention rate of EC with wild-type tPA (39%)
was lower than that without the tPA gene (45%). The
presence of fibrin had no significant difference on the cell
retention rate for grafts seeded with EC or EC transduced
with wild-type tPA (P > .2, n = 4 to 10, Table II). Grafts
seeded with cells carrying the gene for the zymogen
mutant showed significant (P = .001, n = 10) improve-
ment in cell retention (54%) in the absence of fibrin when
compared with those with wild-type tPA (39%). In the
presence of fibrin, the retention rate of cells with zymogen
tPA was significantly (P = .005, n = 4) reduced to 43%,
which was not significantly different than with wild-type
tPA (34%, P = .19, n = 4).
DISCUSSION
There has been various enhancement of EC adhesion
onto synthetic vascular graft surfaces reported: (1) coating
the surface of the grafts with ECM protein ligands, such 
as fibronectin23 or fibronectin together with integrin-
independent (avidin-biotin) proteins24; (2) covalently
attaching cell adhesion peptide sequences, such as Arg-
Gly-Asp25; and (3) generating new molecular functional
groups and changing surface properties by plasma dis-
charge treatment.26 However, the focus of these studies
was on improvement of cell attachment on the graft surface
and did not increase the cell retention rate significantly.
Fibronectin squeezed through PTFE has been
reported to be the most effective technique to increase cell
seeding efficiency.6 Our data support these findings, and
the seeding efficiency of grafts treated by means of the
squeeze-through technique with fibronectin was signifi-
cantly higher than grafts only rinsed with fibronectin (Fig
1), whereas the passive rinsing of PBS onto the hydropho-
bic surface of PTFE yielded a low seeding efficiency. The
improved seeding efficiency with the squeeze-through
technique could result from the reduced hydrophobic
property of the PTFE surface after the fibronectin has
penetrated the fine pores of the PTFE under the squeeze
pressure. The passive rinsing matrix through the graft can
do little to increase the hydrophilicity of the graft surface,
which is essential for cells to attach.
To further improve retention of the seeded cells once
they were exposed to the shear stress of the flowing
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Table II. Activity of tPA and its effect on cell retention
No. of cells on graft‡ (cells/mm2)
Cell seeded* Fibrin† tPA activity (IU/mL) Before flow After flow Retention rate‡ (%)
EC – 1.5 ± 0.1 334 ± 46 152 ± 25 45 ± 5 (10)
+ 1.0 ± 0.1 304 ± 127 130 ± 58 40 ± 8 (4)
EC/wild-type tPA – 30 ± 1.4 229 ± 22 122 ± 19 39 ± 6 (10)
+ 29 ± 8.2 329 ± 49 111 ± 23 34 ± 18 (4)
EC/zg tPA – 14 ± 1.0 250 ± 27 139 ± 50 54 ± 13 (10)
+ 50 ± 19 255 ± 19 113 ± 31 43 ± 8 (4)
*PTFE (5-mm internal diameter) was seeded with EC, EC transduced with wild-type tPA (EC/wt tPA), or EC transduced with zymogen tPA (EC/zg tPA)
24 hours before exposure to flow. The grafts were exposed to a flow as described in Table I.
†The fibrin (25 µg/mL) was added (+) or not added (–) to the medium in the flow circuit.
‡Cells on the graft were counted under a microscope in 10 random fields. Retention rate is the number of cells on a postflow graft expressed as a ratio of
the number of cells on a preflow graft. Numbers represent the mean ± SE of the number of cells on the grafts examined (shown in parentheses).
Table I. Retention of seeded cells on PTFE graft after exposed flow in vitro
No. of cells on graft† (cells/mm2)
Cell seeded* Before flow After flow Retention rate‡ (%)
EC only 358 ± 19 (10) 137 ± 14 (10) 39 ± 14
SMC only 201 ± 9 (13) 126 ± 12 (13) 64 ± 23
EC on top of SMC 330 ± 14 (10) 243 ± 27 (10) 73 ± 22
*PTFE (5-mm internal diameter) was seeded with EC alone, SMC alone, or EC on top of SMC 24 hours before exposure to flow. The grafts were exposed
to a flow of culture medium at a rate of 500 mL/min (shear stress = 6.1 dyne/cm2) for 60 minutes in vitro.
†Cells on the graft were counted under a microscope in 10 random fields. Numbers represent the mean ± SE of the number of cells on the grafts examined
(shown in parentheses).
‡Retention rate is the number of cells on a postflow graft expressed as a ratio of the number of cells on a preflow graft.
medium, we added vascular SMC as an additional layer
between the EC and the graft surface. Vascular SMC are a
major cellular component of the vessel wall, secreting sig-
nificant amounts of extracellular matrix components.27
SMC seeded alone had a better retention rate (64%) than
EC seeded alone (39%) (Table I), perhaps because of the
expression of ECM on seeded cells to enhance adhesion.
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EC seeded on top of the SMC also resulted in a higher
retention rate (73%) than EC seeded alone. Ono et al28
have shown that EC-conditioned medium stimulated the
adhesion and growth of SMC, suggesting EC produce and
secrete accelerators for the adhesion of SMC. Therefore,
the higher retention rate in dual seeding could be a result
of the better adhesion of SMC on graft surface, or the
Fig 2. Distinguishing SMC from EC on dual-cell–seeded PTFE graft. SMC and EC were transduced with GFP and lacZ marker genes,
respectively. GFP-transduced SMC were seeded on PTFE, and EC were seeded on top of SMC 1 day later. Dual-seeded graft was stained
with X-gal. Under phase contract microscopy (a, Original magnification × 40), only EC in blue can be seen. Under fluorescent
microscopy (b), SMC (in green) and EC (in dark spots) can be distinguished. GFP-transduced SMC grown on a culture dish (c) was
compared with SMC grown on PTFE (d).
Fig 3. Cell retention on PTFE grafts. PTFE grafts seeded with EC alone (a, d), SMC alone (b, e), and EC on top of SMC (c, f) were
exposed to flow in vitro for 60 minutes. EC were stained by X-gal, which shows blue color. SMC were stained with hematoxylin and eosin.
Upper panels are cells before flow; lower panels are cells after flow. Dual seeding significantly improves surface retention of cells (c, f).
interaction between EC and SMC increases the cell adhe-
sion. The 87% improvement of the retention rate for EC
seeded on top of SMC compared with EC seeded alone
suggests that the SMC provide a more effective way for
retaining EC on artificial graft surfaces. The growth pat-
tern and physiologic properties of SMC lend themselves to
an excellent nature matrix for the attachment of EC. The
dual-cell seeding on the surface of prosthetic grafts will
best mimic the natural structure of vessels. In addition,
SMC provide a multilayer network of cells, allowing for
increased production of exogenous gene product when
transduced with a selected therapeutic gene. This higher
quantity of cell-producing unit per unit area can be used
in the design of a graft that acts as an intravascular drug
delivery unit.
A concern of use of SMC with this dual-layer model is
the lack of control growth of the SMC, which may result
in graft stenosis. However, studies have found that EC
markedly inhibit the SMC growth in a coculture of EC
and SMC.29,30 Because there is an EC layer covering the
SMC layer, the proliferation of SMC may be modulated
and limited by the EC layer. The in vivo studies have also
shown that the extensive neointimal proliferation after
luminal injury was restricted by reendothelialization of
vessel walls.31 Furthermore, either seeded SMC or EC
could be genetically modified by transferring a gene cod-
ing for nitric oxide synthase (NOS) to stimulate produc-
tion of nitric oxide, which has been shown to inhibit the
SMC proliferation and mitogenesis responsible for intimal
hyperplasia.32,33 Gene transfer of NOS into EC has also
been successful in reducing SMC hyperplasia.34,35
Therefore, the proliferation of seeded SMC could be con-
trolled by both EC and NOS gene transduction.
The seeding of tPA-transduced cells onto grafts has
been proposed to enhance thrombolytic activity of the
grafts and thereby to improve graft patency. In addition to
direct thrombolysis, inhibition of the fibrin cross-linked
stabilization of the platelet coagulum by in situ overex-
pression of a thrombolytic agent may have the added ben-
efit of slowing the development of myointimal hyperplasia
and atherosclerosis within or in the outflow vasculature
distally, hence, improving graft patency. However, overex-
pression of tPA has been shown to further decrease reten-
tion of seeded EC on prosthetic grafts because the
wild-type tPA is secreted from cells as an active protease
that induces nonspecific proteolysis of the supporting
extracellular matrix, thus reducing the adhesion of EC to
the graft surface.12,13
To avoid the tPA-induced reduction of cell retention,
we have applied zymogen tPA in this study and shown that
the tPA production of seeded cells can be increased with-
out sacrificing their retention efficiency. Zymogen mutant
tPA has been reported to display a reduction in catalytic
efficiency by a factor of 200 in the single-chain form, while
retaining full activity in its cleaved form, which is accom-
plished by binding to fibrin.14 We observed that the reten-
tion rate of cells with the zymogen tPA was significantly
higher in the absence of fibrin than that with wild-type
tPA (Table II). In the presence of fibrin, the protease
activity increased about fivefold (Table II), and the reten-
tion rate of cells with zymogen tPA was significantly
reduced to a similar level as that with wild-type tPA. These
results fit our hypothesis that lower protease activity asso-
ciated with zymogen tPA will have limited digestion of
ECM, resulting in better cell retention; increased tPA
activity induced by fibrin leads to ECM digestion and
lower cell retention.
The property of low enzymatic activity of mutant
zymogen tPA in absence of fibrin is beneficial because the
increase of zymogen tPA production in the cells will not
increase protease activity significantly inside the cells when
the zymogen tPA has not contacted with fibrin outside of
the cells. Once the zymogen tPA is secreted and encoun-
tered fibrin on the lesion site, it will be converted into an
active one. By this way, the nonspecific proteolysis of the
supporting ECM can be minimized and the cell retention
be increased, whereas the antithrombosis ability will be
enhanced.
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